Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.33250219 |
2 | tricarboxylic acid cycle (GO:0006099) | 4.26617375 |
3 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.23874340 |
4 | NADH metabolic process (GO:0006734) | 4.19349833 |
5 | cell communication by electrical coupling (GO:0010644) | 4.15817936 |
6 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.08836466 |
7 | adhesion of symbiont to host cell (GO:0044650) | 3.95549061 |
8 | virion attachment to host cell (GO:0019062) | 3.95549061 |
9 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.83978377 |
10 | regulation of extracellular matrix disassembly (GO:0010715) | 3.65160165 |
11 | skin morphogenesis (GO:0043589) | 3.58215548 |
12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.57269030 |
13 | sodium ion export (GO:0071436) | 3.55863712 |
14 | cellular potassium ion homeostasis (GO:0030007) | 3.55053191 |
15 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.54131803 |
16 | adhesion of symbiont to host (GO:0044406) | 3.50214167 |
17 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.34060463 |
18 | aspartate family amino acid catabolic process (GO:0009068) | 3.33056431 |
19 | 2-oxoglutarate metabolic process (GO:0006103) | 3.30447783 |
20 | barbed-end actin filament capping (GO:0051016) | 3.30055439 |
21 | type B pancreatic cell proliferation (GO:0044342) | 3.28100711 |
22 | protein heterotrimerization (GO:0070208) | 3.26939948 |
23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.26604148 |
24 | endodermal cell differentiation (GO:0035987) | 3.23017302 |
25 | potassium ion import (GO:0010107) | 3.19249453 |
26 | lysine catabolic process (GO:0006554) | 3.19067549 |
27 | lysine metabolic process (GO:0006553) | 3.19067549 |
28 | cell communication involved in cardiac conduction (GO:0086065) | 3.18614898 |
29 | cell adhesion mediated by integrin (GO:0033627) | 3.17494402 |
30 | succinate metabolic process (GO:0006105) | 3.15923752 |
31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.15383712 |
32 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.13974935 |
33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.11406580 |
34 | biotin metabolic process (GO:0006768) | 3.10993718 |
35 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.10697847 |
36 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10374202 |
37 | creatine metabolic process (GO:0006600) | 3.07799041 |
38 | short-chain fatty acid metabolic process (GO:0046459) | 3.06187747 |
39 | sarcomere organization (GO:0045214) | 3.02596453 |
40 | regulation of membrane repolarization (GO:0060306) | 3.02595582 |
41 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.00444089 |
42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.98090166 |
43 | cellular ketone body metabolic process (GO:0046950) | 2.97916602 |
44 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.97706772 |
45 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.94616494 |
46 | mannose metabolic process (GO:0006013) | 2.94358349 |
47 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.94233641 |
48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93596453 |
49 | protein carboxylation (GO:0018214) | 2.93596453 |
50 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.91863060 |
51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.90435943 |
52 | carnitine shuttle (GO:0006853) | 2.89248825 |
53 | ketone body metabolic process (GO:1902224) | 2.88570967 |
54 | fatty acid beta-oxidation (GO:0006635) | 2.88019912 |
55 | regulation of cofactor metabolic process (GO:0051193) | 2.87983601 |
56 | regulation of coenzyme metabolic process (GO:0051196) | 2.87983601 |
57 | positive regulation of extracellular matrix organization (GO:1903055) | 2.84418501 |
58 | cardiac muscle contraction (GO:0060048) | 2.83410288 |
59 | stress fiber assembly (GO:0043149) | 2.83348053 |
60 | cellular sodium ion homeostasis (GO:0006883) | 2.83255126 |
61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.83031872 |
62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.82586395 |
63 | tricarboxylic acid metabolic process (GO:0072350) | 2.82190065 |
64 | protein localization to endosome (GO:0036010) | 2.81704264 |
65 | collagen fibril organization (GO:0030199) | 2.79911815 |
66 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.78621757 |
67 | basement membrane organization (GO:0071711) | 2.78330618 |
68 | fatty acid catabolic process (GO:0009062) | 2.75938842 |
69 | branched-chain amino acid catabolic process (GO:0009083) | 2.74833831 |
70 | cardiac myofibril assembly (GO:0055003) | 2.74649022 |
71 | carnitine metabolic process (GO:0009437) | 2.73871986 |
72 | regulation of fatty acid oxidation (GO:0046320) | 2.73599184 |
73 | respiratory electron transport chain (GO:0022904) | 2.73103400 |
74 | macroautophagy (GO:0016236) | 2.71014209 |
75 | keratan sulfate catabolic process (GO:0042340) | 2.70532152 |
76 | regulation of plasminogen activation (GO:0010755) | 2.69896564 |
77 | cell migration involved in heart development (GO:0060973) | 2.69666003 |
78 | amino-acid betaine metabolic process (GO:0006577) | 2.68948799 |
79 | regulation of actin filament-based movement (GO:1903115) | 2.68795002 |
80 | dicarboxylic acid catabolic process (GO:0043649) | 2.68444801 |
81 | hyaluronan catabolic process (GO:0030214) | 2.67458318 |
82 | electron transport chain (GO:0022900) | 2.66134346 |
83 | positive regulation of sodium ion transport (GO:0010765) | 2.65492454 |
84 | potassium ion homeostasis (GO:0055075) | 2.65022010 |
85 | fatty acid transmembrane transport (GO:1902001) | 2.64459468 |
86 | venous blood vessel morphogenesis (GO:0048845) | 2.63743263 |
87 | protein retention in ER lumen (GO:0006621) | 2.63384645 |
88 | extracellular fibril organization (GO:0043206) | 2.62515955 |
89 | extracellular matrix assembly (GO:0085029) | 2.62096573 |
90 | apoptotic cell clearance (GO:0043277) | 2.59924990 |
91 | blood vessel maturation (GO:0001955) | 2.58149098 |
92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.57445532 |
93 | ATP synthesis coupled proton transport (GO:0015986) | 2.57445532 |
94 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.55494563 |
95 | lipid oxidation (GO:0034440) | 2.55333504 |
96 | regulation of fibrinolysis (GO:0051917) | 2.55208986 |
97 | acetyl-CoA metabolic process (GO:0006084) | 2.55191005 |
98 | fibril organization (GO:0097435) | 2.55029197 |
99 | Golgi transport vesicle coating (GO:0048200) | 2.54634030 |
100 | COPI coating of Golgi vesicle (GO:0048205) | 2.54634030 |
101 | fatty acid oxidation (GO:0019395) | 2.53706858 |
102 | negative regulation of fibrinolysis (GO:0051918) | 2.53297309 |
103 | neuromuscular process controlling posture (GO:0050884) | 2.52545896 |
104 | plasma membrane repair (GO:0001778) | 2.52406458 |
105 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.52402616 |
106 | amino-acid betaine transport (GO:0015838) | 2.50905749 |
107 | carnitine transport (GO:0015879) | 2.50905749 |
108 | collagen metabolic process (GO:0032963) | 2.50391966 |
109 | regulation of sulfur metabolic process (GO:0042762) | 2.50356327 |
110 | carnitine transmembrane transport (GO:1902603) | 2.50262686 |
111 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.47661325 |
112 | regulation of early endosome to late endosome transport (GO:2000641) | 2.47130521 |
113 | synaptic vesicle exocytosis (GO:0016079) | 2.45695448 |
114 | gamma-aminobutyric acid transport (GO:0015812) | 2.45394388 |
115 | branched-chain amino acid metabolic process (GO:0009081) | 2.44384171 |
116 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.44194292 |
117 | monocarboxylic acid catabolic process (GO:0072329) | 2.43750108 |
118 | C4-dicarboxylate transport (GO:0015740) | 2.43502388 |
119 | cardiac muscle cell action potential (GO:0086001) | 2.43494576 |
120 | oxaloacetate metabolic process (GO:0006107) | 2.42814413 |
121 | regulation of collagen metabolic process (GO:0010712) | 2.42531418 |
122 | fibrinolysis (GO:0042730) | 2.41867249 |
123 | regulation of synapse structural plasticity (GO:0051823) | 2.41720173 |
124 | collagen catabolic process (GO:0030574) | 2.41653458 |
125 | synaptic vesicle maturation (GO:0016188) | 2.39723983 |
126 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.39435311 |
127 | acyl-CoA biosynthetic process (GO:0071616) | 2.39403562 |
128 | thioester biosynthetic process (GO:0035384) | 2.39403562 |
129 | tooth mineralization (GO:0034505) | 2.39266339 |
130 | fructose metabolic process (GO:0006000) | 2.38903395 |
131 | endocytic recycling (GO:0032456) | 2.38666702 |
132 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.38045812 |
133 | chondroitin sulfate catabolic process (GO:0030207) | 2.37854737 |
134 | substrate-dependent cell migration (GO:0006929) | 2.37749512 |
135 | positive regulation of receptor recycling (GO:0001921) | 2.37231516 |
136 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.36602035 |
137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.36421490 |
138 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.35862542 |
139 | activation of protein kinase A activity (GO:0034199) | 2.35655426 |
140 | kidney mesenchyme development (GO:0072074) | 2.35220849 |
141 | regulation of extracellular matrix organization (GO:1903053) | 2.35078940 |
142 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.34737610 |
143 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.34359037 |
144 | alpha-linolenic acid metabolic process (GO:0036109) | 2.34019388 |
145 | response to mercury ion (GO:0046689) | 2.33821869 |
146 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.32864847 |
147 | detection of calcium ion (GO:0005513) | 2.32829796 |
148 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32634987 |
149 | relaxation of cardiac muscle (GO:0055119) | 2.32054101 |
150 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.31556735 |
151 | glutamate secretion (GO:0014047) | 2.31469891 |
152 | extracellular matrix disassembly (GO:0022617) | 2.31305805 |
153 | alanine transport (GO:0032328) | 2.30744580 |
154 | myofibril assembly (GO:0030239) | 2.30638939 |
155 | positive regulation of fibroblast migration (GO:0010763) | 2.29551060 |
156 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.29519473 |
157 | platelet degranulation (GO:0002576) | 2.29272840 |
158 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.28524061 |
159 | oxidative phosphorylation (GO:0006119) | 2.27516130 |
160 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.27364493 |
161 | response to laminar fluid shear stress (GO:0034616) | 2.26866594 |
162 | locomotory exploration behavior (GO:0035641) | 2.25442098 |
163 | multicellular organismal catabolic process (GO:0044243) | 2.25150682 |
164 | cellular response to vitamin (GO:0071295) | 2.23386586 |
165 | positive regulation of axon extension (GO:0045773) | 2.21752282 |
166 | multicellular organismal metabolic process (GO:0044236) | 2.21240168 |
167 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.19894612 |
168 | chondrocyte proliferation (GO:0035988) | 2.19120385 |
169 | glycosphingolipid catabolic process (GO:0046479) | 2.18756598 |
170 | peptidyl-proline hydroxylation (GO:0019511) | 2.11239212 |
171 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.10575552 |
172 | response to fluid shear stress (GO:0034405) | 2.08928018 |
173 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.08917189 |
174 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.08424085 |
175 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.07673174 |
176 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.07355393 |
177 | bone trabecula formation (GO:0060346) | 2.06950895 |
178 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.04876610 |
179 | cellular response to nutrient (GO:0031670) | 2.04660548 |
180 | regulation of collagen biosynthetic process (GO:0032965) | 2.04621213 |
181 | metanephric mesenchyme development (GO:0072075) | 2.03935003 |
182 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.03471813 |
183 | negative regulation of adherens junction organization (GO:1903392) | 2.03147365 |
184 | negative regulation of focal adhesion assembly (GO:0051895) | 2.03147365 |
185 | negative regulation of cell junction assembly (GO:1901889) | 2.03147365 |
186 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.00757255 |
187 | chondroitin sulfate biosynthetic process (GO:0030206) | 1.99340379 |
188 | extracellular matrix organization (GO:0030198) | 1.99263038 |
189 | decidualization (GO:0046697) | 1.99208238 |
190 | negative regulation of complement activation (GO:0045916) | 1.98959982 |
191 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.98760597 |
192 | extracellular structure organization (GO:0043062) | 1.98339019 |
193 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.97831627 |
194 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.96570065 |
195 | positive regulation of collagen metabolic process (GO:0010714) | 1.96055529 |
196 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 1.95946450 |
197 | glycolipid catabolic process (GO:0019377) | 1.95633304 |
198 | negative regulation of protein activation cascade (GO:2000258) | 1.94857034 |
199 | glial cell migration (GO:0008347) | 1.94343396 |
200 | oligosaccharide catabolic process (GO:0009313) | 1.94247321 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50575683 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.81928767 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.07706120 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59109584 |
5 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.53691284 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.34627002 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.33458912 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.25680606 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24761581 |
10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.07146918 |
11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.05967074 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97722668 |
13 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.94752387 |
14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94462631 |
15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.89902697 |
16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86336925 |
17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85754094 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84195936 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82191023 |
20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81482859 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79288530 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75895419 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73190626 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71920918 |
25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71805052 |
26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70796059 |
27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70796059 |
28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70783439 |
29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64915043 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64799628 |
31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63430804 |
32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61871403 |
33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.61254056 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59658558 |
35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57536904 |
36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53407968 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51784239 |
38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51436533 |
39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49767981 |
40 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49365832 |
41 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.48257944 |
42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46701615 |
43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46275787 |
44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46084068 |
45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.44692498 |
46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42137500 |
47 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.41313743 |
48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39588617 |
49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38349449 |
50 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38219857 |
51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37624905 |
52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36790109 |
53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36315249 |
54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35361400 |
55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34307159 |
56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29079284 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27625704 |
58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26167752 |
59 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24660035 |
60 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24660035 |
61 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.24450109 |
62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23934266 |
63 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23187439 |
64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.21868108 |
65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21858865 |
66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20449732 |
67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17697517 |
68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17569068 |
69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17068829 |
70 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16523179 |
71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15267295 |
72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14049888 |
73 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13021834 |
74 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12987073 |
75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12725709 |
76 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.10926195 |
77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10603476 |
78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10418577 |
79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10371044 |
80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08657030 |
81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08601745 |
82 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.08193922 |
83 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07463944 |
84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07306258 |
85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06572046 |
86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05377651 |
87 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02802244 |
88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02723257 |
89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02262678 |
90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00820788 |
91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00820788 |
92 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99844383 |
93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99222669 |
94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99058877 |
95 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98788146 |
96 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97839862 |
97 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97292486 |
98 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97152912 |
99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96958973 |
100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96524321 |
101 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96362870 |
102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95218628 |
103 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94825632 |
104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94695527 |
105 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94545728 |
106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94494628 |
107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93709758 |
108 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93225364 |
109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92981144 |
110 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92952338 |
111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92024456 |
112 | P68_20966046_ChIP-Seq_HELA_Human | 0.91670417 |
113 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90958193 |
114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90927150 |
115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90918952 |
116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90005226 |
117 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89669556 |
118 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89561960 |
119 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88962478 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87684697 |
121 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87476871 |
122 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86412790 |
123 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85810264 |
124 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85703247 |
125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85580360 |
126 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85413894 |
127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.84293996 |
128 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82970331 |
129 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82148354 |
130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.81254950 |
131 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80694823 |
132 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80275974 |
133 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80131283 |
134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79506891 |
135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79064003 |
136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78599291 |
137 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77756981 |
138 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.77657023 |
139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77598113 |
140 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77289766 |
141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76413699 |
142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75833587 |
143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75427602 |
144 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74827932 |
145 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.74819783 |
146 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.74514165 |
147 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72991871 |
148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72639564 |
149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72465380 |
150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72249594 |
151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72237133 |
152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71806552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 6.21022277 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 4.45305313 |
3 | MP0003646_muscle_fatigue | 3.61073934 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.28895254 |
5 | MP0000751_myopathy | 3.25092321 |
6 | MP0004215_abnormal_myocardial_fiber | 3.10857173 |
7 | MP0004084_abnormal_cardiac_muscle | 3.01615218 |
8 | MP0005257_abnormal_intraocular_pressure | 2.78753129 |
9 | MP0005503_abnormal_tendon_morphology | 2.77985113 |
10 | MP0004272_abnormal_basement_membrane | 2.72905110 |
11 | MP0005275_abnormal_skin_tensile | 2.61874910 |
12 | MP0003329_amyloid_beta_deposits | 2.51983448 |
13 | MP0004036_abnormal_muscle_relaxation | 2.51652603 |
14 | MP0004859_abnormal_synaptic_plasticity | 2.44425848 |
15 | MP0004510_myositis | 2.39197260 |
16 | MP0004130_abnormal_muscle_cell | 2.34699392 |
17 | MP0005330_cardiomyopathy | 2.26725727 |
18 | MP0001542_abnormal_bone_strength | 2.25142125 |
19 | MP0006054_spinal_hemorrhage | 2.20469193 |
20 | MP0003172_abnormal_lysosome_physiology | 2.17607647 |
21 | MP0003300_gastrointestinal_ulcer | 2.08600861 |
22 | MP0000749_muscle_degeneration | 2.06486226 |
23 | MP0003566_abnormal_cell_adhesion | 2.03548524 |
24 | MP0003195_calcinosis | 1.94585409 |
25 | MP0000013_abnormal_adipose_tissue | 1.92907528 |
26 | MP0003137_abnormal_impulse_conducting | 1.90853854 |
27 | MP0004043_abnormal_pH_regulation | 1.90724189 |
28 | MP0009780_abnormal_chondrocyte_physiolo | 1.89778671 |
29 | MP0010368_abnormal_lymphatic_system | 1.88300987 |
30 | MP0003091_abnormal_cell_migration | 1.87142061 |
31 | MP0005332_abnormal_amino_acid | 1.85994787 |
32 | MP0002909_abnormal_adrenal_gland | 1.85916994 |
33 | MP0002295_abnormal_pulmonary_circulatio | 1.84267466 |
34 | * MP0009840_abnormal_foam_cell | 1.81865668 |
35 | MP0002972_abnormal_cardiac_muscle | 1.78182160 |
36 | MP0002139_abnormal_hepatobiliary_system | 1.73865922 |
37 | MP0005023_abnormal_wound_healing | 1.72257483 |
38 | MP0000747_muscle_weakness | 1.71553155 |
39 | MP0005670_abnormal_white_adipose | 1.68013774 |
40 | MP0003635_abnormal_synaptic_transmissio | 1.67383759 |
41 | MP0004270_analgesia | 1.62385632 |
42 | MP0005620_abnormal_muscle_contractility | 1.61157293 |
43 | MP0002269_muscular_atrophy | 1.60223970 |
44 | MP0000750_abnormal_muscle_regeneration | 1.54150777 |
45 | MP0000767_abnormal_smooth_muscle | 1.52337394 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.51890814 |
47 | MP0005623_abnormal_meninges_morphology | 1.51733891 |
48 | MP0000343_altered_response_to | 1.50198079 |
49 | MP0004484_altered_response_of | 1.50028832 |
50 | MP0008775_abnormal_heart_ventricle | 1.49944306 |
51 | MP0004087_abnormal_muscle_fiber | 1.49896200 |
52 | MP0010386_abnormal_urinary_bladder | 1.48789959 |
53 | MP0006082_CNS_inflammation | 1.48325881 |
54 | MP0006138_congestive_heart_failure | 1.48059923 |
55 | MP0004858_abnormal_nervous_system | 1.46390509 |
56 | MP0003880_abnormal_central_pattern | 1.45432424 |
57 | MP0002064_seizures | 1.43814510 |
58 | MP0005385_cardiovascular_system_phenoty | 1.43009231 |
59 | MP0001544_abnormal_cardiovascular_syste | 1.43009231 |
60 | MP0002896_abnormal_bone_mineralization | 1.42515398 |
61 | MP0005360_urolithiasis | 1.40958784 |
62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40877576 |
63 | MP0004885_abnormal_endolymph | 1.39644765 |
64 | MP0002254_reproductive_system_inflammat | 1.39625823 |
65 | MP0005085_abnormal_gallbladder_physiolo | 1.38243246 |
66 | MP0009046_muscle_twitch | 1.36039607 |
67 | MP0004085_abnormal_heartbeat | 1.35960897 |
68 | MP0003690_abnormal_glial_cell | 1.35515073 |
69 | MP0005451_abnormal_body_composition | 1.32986520 |
70 | MP0001440_abnormal_grooming_behavior | 1.32321467 |
71 | MP0005058_abnormal_lysosome_morphology | 1.31721313 |
72 | MP0002998_abnormal_bone_remodeling | 1.31420475 |
73 | MP0001533_abnormal_skeleton_physiology | 1.29015060 |
74 | MP0005595_abnormal_vascular_smooth | 1.28912346 |
75 | MP0004145_abnormal_muscle_electrophysio | 1.27604897 |
76 | MP0005508_abnormal_skeleton_morphology | 1.27324572 |
77 | MP0005365_abnormal_bile_salt | 1.27094382 |
78 | MP0002822_catalepsy | 1.26550090 |
79 | MP0003950_abnormal_plasma_membrane | 1.26301021 |
80 | MP0003075_altered_response_to | 1.26298467 |
81 | MP0004233_abnormal_muscle_weight | 1.25557652 |
82 | MP0003011_delayed_dark_adaptation | 1.22050363 |
83 | MP0000604_amyloidosis | 1.19431486 |
84 | MP0002090_abnormal_vision | 1.18729711 |
85 | MP0005551_abnormal_eye_electrophysiolog | 1.17640001 |
86 | MP0005164_abnormal_response_to | 1.17237216 |
87 | MP0002063_abnormal_learning/memory/cond | 1.17129670 |
88 | * MP0002118_abnormal_lipid_homeostasis | 1.16510312 |
89 | MP0009745_abnormal_behavioral_response | 1.15963769 |
90 | MP0002272_abnormal_nervous_system | 1.15069320 |
91 | * MP0010329_abnormal_lipoprotein_level | 1.14485034 |
92 | MP0002106_abnormal_muscle_physiology | 1.13662368 |
93 | MP0003436_decreased_susceptibility_to | 1.13605342 |
94 | MP0003303_peritoneal_inflammation | 1.12939010 |
95 | MP0005390_skeleton_phenotype | 1.12205884 |
96 | MP0009384_cardiac_valve_regurgitation | 1.10928413 |
97 | MP0004924_abnormal_behavior | 1.08607360 |
98 | MP0005386_behavior/neurological_phenoty | 1.08607360 |
99 | MP0005666_abnormal_adipose_tissue | 1.08599458 |
100 | MP0005464_abnormal_platelet_physiology | 1.08402654 |
101 | MP0004019_abnormal_vitamin_homeostasis | 1.07957133 |
102 | MP0005535_abnormal_body_temperature | 1.07313436 |
103 | MP0003879_abnormal_hair_cell | 1.07044492 |
104 | MP0006035_abnormal_mitochondrial_morpho | 1.06683624 |
105 | MP0002060_abnormal_skin_morphology | 1.05385394 |
106 | MP0001243_abnormal_dermal_layer | 1.05100875 |
107 | MP0002877_abnormal_melanocyte_morpholog | 1.04184869 |
108 | MP0000230_abnormal_systemic_arterial | 1.03964111 |
109 | MP0002933_joint_inflammation | 1.02236964 |
110 | MP0001756_abnormal_urination | 1.00804161 |
111 | MP0005369_muscle_phenotype | 0.98241758 |
112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97276213 |
113 | MP0008569_lethality_at_weaning | 0.96648213 |
114 | MP0002572_abnormal_emotion/affect_behav | 0.96050904 |
115 | MP0002734_abnormal_mechanical_nocicepti | 0.95876577 |
116 | MP0001486_abnormal_startle_reflex | 0.95529394 |
117 | MP0003283_abnormal_digestive_organ | 0.93531421 |
118 | MP0000920_abnormal_myelination | 0.93515250 |
119 | MP0002638_abnormal_pupillary_reflex | 0.93421842 |
120 | MP0005423_abnormal_somatic_nervous | 0.93186214 |
121 | MP0005377_hearing/vestibular/ear_phenot | 0.93007476 |
122 | MP0003878_abnormal_ear_physiology | 0.93007476 |
123 | MP0005646_abnormal_pituitary_gland | 0.92763352 |
124 | MP0010630_abnormal_cardiac_muscle | 0.92420241 |
125 | MP0003633_abnormal_nervous_system | 0.91704089 |
126 | MP0003868_abnormal_feces_composition | 0.91321163 |
127 | MP0002067_abnormal_sensory_capabilities | 0.91090837 |
128 | MP0008004_abnormal_stomach_pH | 0.90768353 |
129 | MP0000759_abnormal_skeletal_muscle | 0.90695304 |
130 | MP0003806_abnormal_nucleotide_metabolis | 0.89926989 |
131 | MP0003279_aneurysm | 0.89909244 |
132 | MP0003828_pulmonary_edema | 0.89766839 |
133 | MP0000003_abnormal_adipose_tissue | 0.89753531 |
134 | MP0005375_adipose_tissue_phenotype | 0.89338665 |
135 | MP0003191_abnormal_cellular_cholesterol | 0.88271965 |
136 | MP0009643_abnormal_urine_homeostasis | 0.86851607 |
137 | MP0009053_abnormal_anal_canal | 0.86676738 |
138 | MP0004883_abnormal_blood_vessel | 0.86157477 |
139 | MP0003795_abnormal_bone_structure | 0.85678811 |
140 | MP0002078_abnormal_glucose_homeostasis | 0.85124695 |
141 | MP0002332_abnormal_exercise_endurance | 0.84690535 |
142 | MP0001958_emphysema | 0.83878804 |
143 | MP0001984_abnormal_olfaction | 0.83243121 |
144 | MP0002876_abnormal_thyroid_physiology | 0.82198850 |
145 | MP0001502_abnormal_circadian_rhythm | 0.81946847 |
146 | MP0005165_increased_susceptibility_to | 0.81903862 |
147 | * MP0002229_neurodegeneration | 0.81784173 |
148 | MP0001849_ear_inflammation | 0.81763531 |
149 | MP0003045_fibrosis | 0.81312011 |
150 | MP0000534_abnormal_ureter_morphology | 0.81054467 |
151 | MP0002108_abnormal_muscle_morphology | 0.81054201 |
152 | MP0001299_abnormal_eye_distance/ | 0.80473251 |
153 | * MP0003634_abnormal_glial_cell | 0.78529638 |
154 | MP0005166_decreased_susceptibility_to | 0.76513975 |
155 | MP0002168_other_aberrant_phenotype | 0.76369978 |
156 | MP0003448_altered_tumor_morphology | 0.75212146 |
157 | MP0001348_abnormal_lacrimal_gland | 0.73502732 |
158 | MP0000249_abnormal_blood_vessel | 0.73376213 |
159 | MP0000733_abnormal_muscle_development | 0.71652044 |
160 | MP0001915_intracranial_hemorrhage | 0.70974607 |
161 | MP0003724_increased_susceptibility_to | 0.70764056 |
162 | MP0000858_altered_metastatic_potential | 0.70351050 |
163 | MP0008260_abnormal_autophagy | 0.69514824 |
164 | MP0005409_darkened_coat_color | 0.69498654 |
165 | MP0000538_abnormal_urinary_bladder | 0.65341869 |
166 | MP0008874_decreased_physiological_sensi | 0.64777293 |
167 | MP0002419_abnormal_innate_immunity | 0.60396514 |
168 | MP0001614_abnormal_blood_vessel | 0.59979811 |
169 | MP0002128_abnormal_blood_circulation | 0.59812429 |
170 | MP0009764_decreased_sensitivity_to | 0.57909624 |
171 | MP0002971_abnormal_brown_adipose | 0.57689937 |
172 | MP0002089_abnormal_postnatal_growth/wei | 0.57302699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 5.81599381 |
2 | Protrusio acetabuli (HP:0003179) | 5.77496241 |
3 | Sudden death (HP:0001699) | 3.88933252 |
4 | Ketoacidosis (HP:0001993) | 3.80883336 |
5 | Exercise-induced myalgia (HP:0003738) | 3.76946926 |
6 | Vertebral compression fractures (HP:0002953) | 3.68022182 |
7 | Bundle branch block (HP:0011710) | 3.58870582 |
8 | Ankle contracture (HP:0006466) | 3.55777717 |
9 | Vascular tortuosity (HP:0004948) | 3.53431415 |
10 | Atrioventricular block (HP:0001678) | 3.45501166 |
11 | Aortic dissection (HP:0002647) | 3.45463199 |
12 | Type 1 muscle fiber predominance (HP:0003803) | 3.42269490 |
13 | Dysostosis multiplex (HP:0000943) | 3.40449388 |
14 | Aortic aneurysm (HP:0004942) | 3.39877710 |
15 | Hyperglycinuria (HP:0003108) | 3.35245262 |
16 | Myoglobinuria (HP:0002913) | 3.30418459 |
17 | Ketosis (HP:0001946) | 3.21306150 |
18 | Follicular hyperkeratosis (HP:0007502) | 3.20916440 |
19 | Muscle fiber splitting (HP:0003555) | 3.18508870 |
20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.18453832 |
21 | Mucopolysacchariduria (HP:0008155) | 3.18453832 |
22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18275570 |
23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18275570 |
24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18275570 |
25 | Cervical subluxation (HP:0003308) | 3.16591401 |
26 | Hypoglycemic coma (HP:0001325) | 3.14992133 |
27 | Heart block (HP:0012722) | 3.13587172 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.11688118 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.11688118 |
30 | Syncope (HP:0001279) | 3.11677471 |
31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07354498 |
32 | Arterial tortuosity (HP:0005116) | 3.07252888 |
33 | Gout (HP:0001997) | 3.07044992 |
34 | Ventricular fibrillation (HP:0001663) | 3.06076716 |
35 | Peritonitis (HP:0002586) | 3.04141857 |
36 | Pheochromocytoma (HP:0002666) | 3.03568072 |
37 | Wormian bones (HP:0002645) | 2.98088919 |
38 | Spinal rigidity (HP:0003306) | 2.97590576 |
39 | Increased variability in muscle fiber diameter (HP:0003557) | 2.97046434 |
40 | Abnormal atrioventricular conduction (HP:0005150) | 2.94485480 |
41 | Slender build (HP:0001533) | 2.94423379 |
42 | Exercise-induced muscle cramps (HP:0003710) | 2.92725873 |
43 | Hyperglycinemia (HP:0002154) | 2.84128022 |
44 | Hepatic necrosis (HP:0002605) | 2.83805759 |
45 | Dicarboxylic aciduria (HP:0003215) | 2.83368435 |
46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83368435 |
47 | Hyperammonemia (HP:0001987) | 2.82844615 |
48 | Bladder diverticulum (HP:0000015) | 2.82275064 |
49 | Mitral stenosis (HP:0001718) | 2.81269380 |
50 | Calf muscle hypertrophy (HP:0008981) | 2.81169081 |
51 | Atrophic scars (HP:0001075) | 2.80713282 |
52 | Soft skin (HP:0000977) | 2.80665033 |
53 | Ventricular tachycardia (HP:0004756) | 2.80188004 |
54 | Abnormality of dentin (HP:0010299) | 2.78018226 |
55 | Systemic lupus erythematosus (HP:0002725) | 2.76544758 |
56 | Neuroendocrine neoplasm (HP:0100634) | 2.72931883 |
57 | Neurofibrillary tangles (HP:0002185) | 2.71129249 |
58 | Blue sclerae (HP:0000592) | 2.70161469 |
59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69161691 |
60 | Abnormality of alanine metabolism (HP:0010916) | 2.69161691 |
61 | Hyperalaninemia (HP:0003348) | 2.69161691 |
62 | Spondylolisthesis (HP:0003302) | 2.66564514 |
63 | Genu recurvatum (HP:0002816) | 2.64392821 |
64 | Atrial fibrillation (HP:0005110) | 2.60791316 |
65 | Cerebral aneurysm (HP:0004944) | 2.56678506 |
66 | Fragile skin (HP:0001030) | 2.56491652 |
67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.56020925 |
68 | Dilatation of the ascending aorta (HP:0005111) | 2.55946000 |
69 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54115086 |
70 | Asymmetric septal hypertrophy (HP:0001670) | 2.53529609 |
71 | Palpitations (HP:0001962) | 2.52731266 |
72 | Abnormality of the calf musculature (HP:0001430) | 2.52479866 |
73 | Ventricular arrhythmia (HP:0004308) | 2.52349991 |
74 | Distal upper limb amyotrophy (HP:0007149) | 2.49667019 |
75 | Upper limb amyotrophy (HP:0009129) | 2.49667019 |
76 | Cardiovascular calcification (HP:0011915) | 2.49358276 |
77 | Joint stiffness (HP:0001387) | 2.46829035 |
78 | Primary atrial arrhythmia (HP:0001692) | 2.43982189 |
79 | Hepatocellular necrosis (HP:0001404) | 2.38874150 |
80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.37954497 |
81 | Supraventricular tachycardia (HP:0004755) | 2.33595482 |
82 | Neonatal short-limb short stature (HP:0008921) | 2.33568743 |
83 | Cerebral inclusion bodies (HP:0100314) | 2.32391575 |
84 | Prolonged QT interval (HP:0001657) | 2.31987250 |
85 | Shallow orbits (HP:0000586) | 2.31584940 |
86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31389286 |
87 | Hyporeflexia of lower limbs (HP:0002600) | 2.31383933 |
88 | Ovoid vertebral bodies (HP:0003300) | 2.30568518 |
89 | Acute encephalopathy (HP:0006846) | 2.30533354 |
90 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29922106 |
91 | Nuclear cataract (HP:0100018) | 2.28875065 |
92 | Supraventricular arrhythmia (HP:0005115) | 2.28206855 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28122754 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 2.28122754 |
95 | Visual hallucinations (HP:0002367) | 2.25303919 |
96 | Lethargy (HP:0001254) | 2.24886617 |
97 | Lipoatrophy (HP:0100578) | 2.24366630 |
98 | Acute necrotizing encephalopathy (HP:0006965) | 2.23587844 |
99 | Aneurysm (HP:0002617) | 2.22823868 |
100 | Abnormality of the Achilles tendon (HP:0005109) | 2.21712589 |
101 | Hyperextensible skin (HP:0000974) | 2.19299203 |
102 | Increased connective tissue (HP:0009025) | 2.17665151 |
103 | Achilles tendon contracture (HP:0001771) | 2.17587025 |
104 | Right ventricular cardiomyopathy (HP:0011663) | 2.17181730 |
105 | Cerebral edema (HP:0002181) | 2.14731915 |
106 | Wrist flexion contracture (HP:0001239) | 2.14299116 |
107 | Hand muscle atrophy (HP:0009130) | 2.13977027 |
108 | Supranuclear gaze palsy (HP:0000605) | 2.13346525 |
109 | Hypoventilation (HP:0002791) | 2.13223680 |
110 | Vacuolated lymphocytes (HP:0001922) | 2.12508678 |
111 | Difficulty running (HP:0009046) | 2.12413024 |
112 | Methylmalonic aciduria (HP:0012120) | 2.12398419 |
113 | * Athetosis (HP:0002305) | 2.11532134 |
114 | EMG: myopathic abnormalities (HP:0003458) | 2.08582091 |
115 | Dilated cardiomyopathy (HP:0001644) | 2.07942871 |
116 | Focal motor seizures (HP:0011153) | 2.07636216 |
117 | Abnormality of complement system (HP:0005339) | 2.07268281 |
118 | Mitral regurgitation (HP:0001653) | 2.06703306 |
119 | Generalized aminoaciduria (HP:0002909) | 2.06248473 |
120 | Vascular calcification (HP:0004934) | 2.05562652 |
121 | Myokymia (HP:0002411) | 2.05226447 |
122 | Lactic acidosis (HP:0003128) | 2.04659959 |
123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03694868 |
124 | Rhabdomyolysis (HP:0003201) | 2.02351779 |
125 | Biconcave vertebral bodies (HP:0004586) | 2.02183279 |
126 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00199897 |
127 | Aplasia involving bones of the extremities (HP:0009825) | 2.00199897 |
128 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00199897 |
129 | Abnormal EKG (HP:0003115) | 1.99407696 |
130 | Bowel diverticulosis (HP:0005222) | 1.98285823 |
131 | Hyperglycemia (HP:0003074) | 1.98133034 |
132 | Deep venous thrombosis (HP:0002625) | 1.98026934 |
133 | Axonal loss (HP:0003447) | 1.97338164 |
134 | Increased muscle lipid content (HP:0009058) | 1.96589533 |
135 | Complement deficiency (HP:0004431) | 1.94762329 |
136 | Loss of speech (HP:0002371) | 1.94365383 |
137 | CNS demyelination (HP:0007305) | 1.94037960 |
138 | Difficulty climbing stairs (HP:0003551) | 1.93913330 |
139 | Mitochondrial inheritance (HP:0001427) | 1.93893947 |
140 | Aortic regurgitation (HP:0001659) | 1.93313038 |
141 | Global brain atrophy (HP:0002283) | 1.91815042 |
142 | Joint laxity (HP:0001388) | 1.91346559 |
143 | Increased CSF lactate (HP:0002490) | 1.90427939 |
144 | Abnormality of serum amino acid levels (HP:0003112) | 1.89855540 |
145 | Distal lower limb muscle weakness (HP:0009053) | 1.89709463 |
146 | Congenital glaucoma (HP:0001087) | 1.88866524 |
147 | Purpura (HP:0000979) | 1.88353295 |
148 | Myotonia (HP:0002486) | 1.88185653 |
149 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87697514 |
150 | Polycythemia (HP:0001901) | 1.86594737 |
151 | Generalized amyotrophy (HP:0003700) | 1.86070815 |
152 | Large for gestational age (HP:0001520) | 1.85620537 |
153 | Wide anterior fontanel (HP:0000260) | 1.84387654 |
154 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83715217 |
155 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83715217 |
156 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83715217 |
157 | Left ventricular hypertrophy (HP:0001712) | 1.83645936 |
158 | Mitral valve prolapse (HP:0001634) | 1.83538635 |
159 | Metabolic acidosis (HP:0001942) | 1.83325034 |
160 | Progressive macrocephaly (HP:0004481) | 1.82597822 |
161 | Abnormality of the acetabulum (HP:0003170) | 1.82206341 |
162 | Elbow flexion contracture (HP:0002987) | 1.82068715 |
163 | Myocardial infarction (HP:0001658) | 1.81698572 |
164 | Ragged-red muscle fibers (HP:0003200) | 1.80955818 |
165 | Ankle clonus (HP:0011448) | 1.80832920 |
166 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80509896 |
167 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.80224432 |
168 | Osteoarthritis (HP:0002758) | 1.79631350 |
169 | Overgrowth (HP:0001548) | 1.79386223 |
170 | Respiratory failure (HP:0002878) | 1.78863694 |
171 | Nonimmune hydrops fetalis (HP:0001790) | 1.78400854 |
172 | Abnormal delivery (HP:0001787) | 1.77562954 |
173 | Generalized tonic-clonic seizures (HP:0002069) | 1.76521648 |
174 | Anxiety (HP:0000739) | 1.75801346 |
175 | J-shaped sella turcica (HP:0002680) | 1.75644086 |
176 | Increased circulating renin level (HP:0000848) | 1.75337408 |
177 | Central scotoma (HP:0000603) | 1.75246877 |
178 | Aortic valve stenosis (HP:0001650) | 1.74563620 |
179 | Increased cerebral lipofuscin (HP:0011813) | 1.74384768 |
180 | Long toe (HP:0010511) | 1.74047450 |
181 | Proximal tubulopathy (HP:0000114) | 1.73037567 |
182 | * Vomiting (HP:0002013) | 1.71975389 |
183 | Coxa vara (HP:0002812) | 1.71024838 |
184 | Broad metatarsal (HP:0001783) | 1.70274010 |
185 | Round ear (HP:0100830) | 1.67814500 |
186 | Obstructive sleep apnea (HP:0002870) | 1.67246988 |
187 | Thin bony cortex (HP:0002753) | 1.67108425 |
188 | Distal lower limb amyotrophy (HP:0008944) | 1.66395970 |
189 | Emphysema (HP:0002097) | 1.65610369 |
190 | Short nail (HP:0001799) | 1.64408451 |
191 | Hypoplasia of the iris (HP:0007676) | 1.63904172 |
192 | Amyloidosis (HP:0011034) | 1.63277330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK1 | 4.22969818 |
2 | PHKG1 | 3.17648619 |
3 | PHKG2 | 3.17648619 |
4 | BCKDK | 3.07975853 |
5 | TRIB3 | 2.91616385 |
6 | LMTK2 | 2.77470926 |
7 | PDK3 | 2.75737544 |
8 | PDK4 | 2.75737544 |
9 | PINK1 | 2.69235696 |
10 | DDR2 | 2.47387670 |
11 | TESK1 | 2.33224504 |
12 | EPHA4 | 2.22564385 |
13 | EPHA2 | 2.20161668 |
14 | TGFBR2 | 2.18713098 |
15 | MAP3K9 | 2.07857103 |
16 | PRKD2 | 2.01179773 |
17 | TTN | 1.98816162 |
18 | NEK1 | 1.93790258 |
19 | MAP3K3 | 1.82638547 |
20 | LIMK1 | 1.79110410 |
21 | PAK3 | 1.79067187 |
22 | PDK2 | 1.76666071 |
23 | PTK2 | 1.71532854 |
24 | MARK1 | 1.70833066 |
25 | MYLK | 1.69522847 |
26 | IRAK3 | 1.69315017 |
27 | EPHB2 | 1.68441715 |
28 | PRPF4B | 1.64701298 |
29 | EPHB1 | 1.60932575 |
30 | ARAF | 1.60737667 |
31 | NEK9 | 1.57944345 |
32 | PRKD3 | 1.54899379 |
33 | WNK4 | 1.50216854 |
34 | CAMKK2 | 1.49661635 |
35 | MOS | 1.47574863 |
36 | PAK6 | 1.44688503 |
37 | MAPK12 | 1.42810740 |
38 | NTRK3 | 1.40713494 |
39 | MUSK | 1.38743878 |
40 | NTRK1 | 1.38305299 |
41 | KSR2 | 1.35459725 |
42 | STK38 | 1.32166810 |
43 | MAP2K3 | 1.29064656 |
44 | TAOK2 | 1.27817401 |
45 | CAMK2D | 1.25810682 |
46 | ABL2 | 1.23402235 |
47 | MAP3K11 | 1.21270955 |
48 | SIK1 | 1.19757039 |
49 | PIM2 | 1.19465260 |
50 | OBSCN | 1.17261175 |
51 | ZAP70 | 1.13617798 |
52 | MINK1 | 1.11015430 |
53 | PIK3CG | 1.10789909 |
54 | TYK2 | 1.09693106 |
55 | MAP2K4 | 1.08563998 |
56 | SGK223 | 1.08090844 |
57 | SGK494 | 1.08090844 |
58 | CAMKK1 | 1.06802557 |
59 | TIE1 | 1.05242608 |
60 | PAK2 | 1.05071007 |
61 | TBK1 | 1.04850928 |
62 | PRKCG | 1.04782499 |
63 | CAMK2G | 1.04354719 |
64 | PNCK | 1.03893388 |
65 | MAP3K4 | 1.03721972 |
66 | DAPK2 | 1.03528857 |
67 | ICK | 1.03506445 |
68 | NTRK2 | 1.02695907 |
69 | PAK4 | 1.00996410 |
70 | PDPK1 | 0.99644033 |
71 | PTK2B | 0.97744086 |
72 | PRKG2 | 0.97467719 |
73 | OXSR1 | 0.95464556 |
74 | WNK3 | 0.95434140 |
75 | JAK1 | 0.90407606 |
76 | PKN2 | 0.89686169 |
77 | TRPM7 | 0.89362060 |
78 | FER | 0.89316097 |
79 | PRKCE | 0.88885119 |
80 | INSRR | 0.87719097 |
81 | TAOK1 | 0.87226683 |
82 | PRKD1 | 0.86990255 |
83 | CAMK2A | 0.86296328 |
84 | RPS6KA2 | 0.85391178 |
85 | MARK2 | 0.83682979 |
86 | ERN1 | 0.82316196 |
87 | FGFR4 | 0.81543568 |
88 | CAMK2B | 0.81356120 |
89 | PDGFRB | 0.79367956 |
90 | NME1 | 0.79283798 |
91 | CDK5 | 0.78532482 |
92 | CAMK1 | 0.78367858 |
93 | PRKAA1 | 0.77358648 |
94 | BRAF | 0.77145064 |
95 | GRK5 | 0.75864492 |
96 | PIK3CA | 0.75852189 |
97 | MAP2K7 | 0.75027318 |
98 | MAP2K1 | 0.74557095 |
99 | STK38L | 0.73194265 |
100 | DAPK3 | 0.71539258 |
101 | PRKCH | 0.71080236 |
102 | STK24 | 0.70074554 |
103 | LATS2 | 0.67375868 |
104 | STK39 | 0.63004005 |
105 | PTK6 | 0.62917014 |
106 | KDR | 0.62864238 |
107 | MAP3K1 | 0.59758528 |
108 | PDK1 | 0.58216786 |
109 | ROCK1 | 0.57872035 |
110 | JAK3 | 0.57612526 |
111 | ILK | 0.57258236 |
112 | DYRK1B | 0.57238744 |
113 | SGK3 | 0.56935618 |
114 | GSK3A | 0.56625775 |
115 | MAP3K13 | 0.55183173 |
116 | ADRBK1 | 0.55052372 |
117 | FGFR3 | 0.54384821 |
118 | MAP3K6 | 0.53881542 |
119 | MST1R | 0.53497326 |
120 | RET | 0.52860422 |
121 | BMX | 0.52730229 |
122 | HIPK2 | 0.51784348 |
123 | SGK2 | 0.50689950 |
124 | CDK19 | 0.50553537 |
125 | ROCK2 | 0.49276919 |
126 | PDGFRA | 0.48409603 |
127 | MAP3K12 | 0.48380334 |
128 | DMPK | 0.46548767 |
129 | TNIK | 0.45128464 |
130 | MAPKAPK5 | 0.44840348 |
131 | PRKACA | 0.44707333 |
132 | GRK7 | 0.44528134 |
133 | PRKACG | 0.44112511 |
134 | EPHA3 | 0.43677717 |
135 | CDK14 | 0.43572722 |
136 | CDC42BPA | 0.43333990 |
137 | KIT | 0.42726256 |
138 | MTOR | 0.42648779 |
139 | MAPK7 | 0.42511653 |
140 | MAP2K2 | 0.42129888 |
141 | AKT3 | 0.42032600 |
142 | BUB1 | 0.41302567 |
143 | FGFR2 | 0.40914946 |
144 | CDK15 | 0.40000588 |
145 | MAPKAPK3 | 0.39176008 |
146 | MAP3K7 | 0.38816961 |
147 | PRKCZ | 0.38609829 |
148 | MAP3K2 | 0.38380732 |
149 | MAP3K5 | 0.36878847 |
150 | CSK | 0.35820996 |
151 | MET | 0.35520001 |
152 | SRC | 0.34454996 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.68721009 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.34268658 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.19140142 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02636961 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48118808 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40492018 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36021189 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28968793 |
9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.26549523 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25828057 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19122673 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14935071 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13151434 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08534581 |
15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.02862187 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.93619521 |
17 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.91939871 |
18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.89081496 |
19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77129931 |
20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67490450 |
21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67326029 |
22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62455821 |
23 | Focal adhesion_Homo sapiens_hsa04510 | 1.62119139 |
24 | Prion diseases_Homo sapiens_hsa05020 | 1.58426974 |
25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52485637 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51180305 |
27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50936446 |
28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50907663 |
29 | Amoebiasis_Homo sapiens_hsa05146 | 1.44468321 |
30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37034863 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36242136 |
32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31217813 |
33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.31082635 |
34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25601300 |
35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.23962084 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22945004 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.20977722 |
38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17752928 |
39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14160472 |
40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13034348 |
41 | Insulin secretion_Homo sapiens_hsa04911 | 1.12703443 |
42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11367791 |
43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10631476 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10461680 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.09985117 |
46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09004509 |
47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08583010 |
48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07779486 |
49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.05763403 |
50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05628010 |
51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05098701 |
52 | Malaria_Homo sapiens_hsa05144 | 1.03336895 |
53 | Pertussis_Homo sapiens_hsa05133 | 1.01879924 |
54 | Nicotine addiction_Homo sapiens_hsa05033 | 1.01383337 |
55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00661597 |
56 | Phagosome_Homo sapiens_hsa04145 | 1.00043384 |
57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98608397 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98219382 |
59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97760058 |
60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97664696 |
61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97122433 |
62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94305764 |
63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93913585 |
64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92993022 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91544947 |
66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89536502 |
67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89097019 |
68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87566196 |
69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85688961 |
70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85514629 |
71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84811517 |
72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84793607 |
73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83466898 |
74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82999711 |
75 | Salivary secretion_Homo sapiens_hsa04970 | 0.82985059 |
76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81804398 |
77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81794208 |
78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81615722 |
79 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81328494 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.80740645 |
81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78841028 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78132416 |
83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76372232 |
84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76110071 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76088967 |
86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75324306 |
87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75120579 |
88 | Morphine addiction_Homo sapiens_hsa05032 | 0.72453260 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.71473880 |
90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71362451 |
91 | * Lysosome_Homo sapiens_hsa04142 | 0.69643130 |
92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68908407 |
93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.68768454 |
94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68349412 |
95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67921059 |
96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66463578 |
97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66200608 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65774891 |
99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65523944 |
100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65131478 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.65093961 |
102 | Bladder cancer_Homo sapiens_hsa05219 | 0.65055030 |
103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64950765 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64159427 |
105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63142579 |
106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62718348 |
107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62699091 |
108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62355875 |
109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62141823 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.61230995 |
111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60878126 |
112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60557585 |
113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59298715 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.59215386 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58023930 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57682377 |
117 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57033003 |
118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55954145 |
119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55424956 |
120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54872176 |
121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54021619 |
122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53130091 |
123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52791345 |
124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52749940 |
125 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52509402 |
126 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52359715 |
127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52343288 |
128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52046761 |
129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51802227 |
130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51704682 |
131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51494804 |
132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50623407 |
133 | Taste transduction_Homo sapiens_hsa04742 | 0.50620656 |
134 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49857371 |
135 | Tuberculosis_Homo sapiens_hsa05152 | 0.49454367 |
136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47868708 |
137 | Shigellosis_Homo sapiens_hsa05131 | 0.47716442 |
138 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46846912 |
139 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46786296 |
140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46438558 |
141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45486428 |
142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45390475 |
143 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45167801 |
144 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44538169 |
145 | Hepatitis C_Homo sapiens_hsa05160 | 0.43939921 |
146 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43812292 |
147 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43654584 |
148 | Gap junction_Homo sapiens_hsa04540 | 0.43636122 |
149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43282738 |
150 | Insulin resistance_Homo sapiens_hsa04931 | 0.42651591 |
151 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42539578 |
152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41815696 |
153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40921614 |
154 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40305953 |
155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40238288 |
156 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39705747 |
157 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39281202 |
158 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38832649 |
159 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38705931 |
160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38680909 |
161 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37989198 |
162 | Glioma_Homo sapiens_hsa05214 | 0.37960232 |
163 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36937081 |
164 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36841390 |